Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy | Cochrane

Severe myoclonic epilepsy in infants (SMEI), also known as Dravet syndrome, is a rare, drug-resistant form of epilepsy, for which stiripentol (STP) has been recently licensed for treatment when given in combination with other antiepileptic drugs. In this review, we evaluated the efficacy and tole...